What is Vertex Pharmaceuticals's 12 months or more?

Vertex Pharmaceuticals (VRTX) reported 12 months or more of $100.00K in Q1 2026.

How has Vertex Pharmaceuticals's 12 months or more changed year-over-year?

Vertex Pharmaceuticals's 12 months or more decreased by 0.0% year-over-year, from $100.00K to $100.00K.

12 months or more

Vertex Pharmaceuticals 12 months or more remained flat by 0.0% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $100.00K to $100.00K.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ1 2023

Last reportedQ1 2026May 5, 2026

Metric ID: other_debt_securities_available_for_sale_continuous_unre_52a0a6

Historical Data

10 periods

	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$0.00	$0.00	$0.00	$53.80M	$3.50M	$100.00K	$100.00K	$100.00K	$100.00K	$100.00K
QoQ Change	—	—	—	—	-93.5%	-97.1%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	—	—	—	—	-99.8%	-97.1%	+0.0%	+0.0%

Range$0.00 – $53.80M

Avg YoY Growth-49.2%

Median YoY Growth-48.6%

Current Streak4 quarters growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's 12 months or more?: Vertex Pharmaceuticals (VRTX) reported 12 months or more of $100.00K in Q1 2026.
How has Vertex Pharmaceuticals's 12 months or more changed year-over-year?: Vertex Pharmaceuticals's 12 months or more decreased by 0.0% year-over-year, from $100.00K to $100.00K.